Skip to main content
Emergency Alert
×
emergency alert
Notice:
Vendor data security incident
Find a Doctor
Services
Locations
Patients & Visitors
Appointments
Billing
Clinical Trials
MyChart
Search all site content
Search site
Locations
Doctors
UVA Health
Appointments
Billing
Clinical Trials
Careers
MyChart
UVA Health
Find a Doctor
Services
Locations
Patients & Visitors
Search
Menu
Search all site content
Search site
Home
Clinical Trial Categories
Clinical Trials
In This Section
Pediatrics Clinical Trials
Principal Investigator
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma (AOST2031)
A Phase 2 Trial of Chemotherapy followed by Response Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor (ACNS2021)
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors (AGCT1531)
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG). (ACNS1821)
A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features (ACNS2031)
APhase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND #145355) (ACNS1723)
Acute Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Brain Tumor
A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors (ACCL2031)
Healthy Subject Study
Hormone Study for Girls Ages 7 - 14
Hormone Studies
Hormone Study for Girls Ages 7 - 17
Hormone study for overweight girls ages 8 - 16
Hormone Study for Girls Ages 7 - 14
Hormone Study for Adolescent Girls Between the Ages of 10 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Adolescent Hormone Study for Girls Ages 7 - 18
Adolescent Hormone Study for Girls Ages 7 - 18
Leukemia
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations (AAML1831)
Overweight
Hormone study for overweight girls ages 8 - 16
Polycystic Ovarian Syndrome
Hormone Study for Girls Ages 7 - 17
Hormone study for overweight girls ages 8 - 16
Hormone Study for Girls Ages 7 - 14
Hormone Study for Adolescent Girls Between the Ages of 10 - 17
Study for the use of spironolactone to regulate menses in girls with excess male hormone
Adolescent Hormone Study for Girls Ages 7 - 18
Adolescent Hormone Study for Girls Ages 7 - 18
Scoliosis
Research study for children and adults ages 10 to 21 years old with scoliosis
